Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice

International Journal of Neuropsychopharmacology

Volumn 15, Issue 8, 2012, Pages 1073-1086

  Kutiyanawalla, Ammar ^a,b   Promsote, Wanwisa ^a,b   Terry, Alvin ^a   Pillai, Anilkumar ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BDNF; cognition; cysteamine; GAD67; mice; reeler; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLUTAMATE DECARBOXYLASE 67; MERCAPTAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOGNITION; SPATIAL MEMORY;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; CYSTEAMINE; FRONTAL LOBE; GENE EXPRESSION REGULATION; GLUTAMATE DECARBOXYLASE; HETEROZYGOTE; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; MICE; MICE, KNOCKOUT; MICE, NEUROLOGIC MUTANTS; RECEPTOR, TRKB; SENSORY GATING; SPACE PERCEPTION; TIME FACTORS;

EID: 84864570507     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001180     Document Type: Article

References (56)

1. Acri JB, Morse DE, Popke EJ, Grunberg NE (1994). Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats. Psychopharmacology 114, 369-374.
2. Adler LE, Olincy A, Waldo M, Harris JG, et al. (1998). Schizophrenia, sensory gating, and nicotinic receptors. Schizophrenia Bulletin 24, 189-202.
3. Akbarian S, Huang HS (2006). Molecular and cellular mechanisms of altered GAD1/GAD67 epression in schizophrenia and related disorders. Brain Research Reviews 52, 293-304.
4. Alca'ntara S, Ruiz M, D'Arcangelo G, Ezan F, et al. (1998). Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. Journal of Neuroscience 18, 7779-7799.
5. Arenas E, Akerud P, Wong V, Boylan C, et al. (1996). Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo. European Journal of Neuroscience 8, 1707-1717.
6. Asada H, Kawamura Y, Maruyama K, Kume H, et al. (1997). Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proceedings of the National Academy of Sciences USA 94, 6496-6499.
7. Borrell-PagèsM, Canals JM, Cordelières FP, Parker JA, et al. (2006). Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. Journal of Clinical Investigation 116, 1410-1424.
8. Braff DL, Grillion C, Geyer MA (1992). Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry 49, 206-215.
9. Carlino D, Leone E, Di Cola F, Baj G, et al. (2011). Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia. Journal of Psychiatric Research 45, 273-279.
10. Carmona MA, Pozas E, Martinez A, Espinosa-Parrilla JF, et al. (2006). Age-dependent spontaneous hyperexcitability and impairment of GABAergic function in the hippocampus of mice lacking trkB. Cerebral Cortex 16, 47-63.
11. Cho RY, Konecky RO, Carter CS (2006). Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proceedings of the National Academy of Sciences USA 103, 19878-19883.
12. Conrad CD, Lupien SJ, Thanasoulis LC, McEwen BS (1997). The effects of type I and type II corticosteroid receptor agonists on exploratory behavior and spatial memory in the Y-maze. Brain Research 759, 76-83.
13. D'Arcangelo G, Miao GG, Chen SC, Soares HD, et al. (1995). A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719-723.
14. Dellu F, Contarino A, Simon H, Koob GF, et al. (2000). Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiology of Learning and Memory 73, 31-48.
15. Dellu F, Mayo W, Cherkaoui J, Le Moal M, et al. (1992). A two-trial memory task with automated recording: study in young and aged rats. Brain Research 588, 132-139.
16. Duncan GE, Moy SS, Lieberman JA, Koller BH (2006). Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model ofNMDAreceptor hypofunction. Pharmacology Biochemistry and Behavior 85, 481-491.
17. Feifel D, Minor KL (1997). Cysteamine blocks amphetamineinduced deficits in sensorimotor gating. Pharmacology Biochemistry and Behavior 58, 689-693.
18. Ge S, Goh EL, Sailor KA, Kitabatake Y, et al. (2006). GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature 439, 589-593.
19. Geyer MA, McIlwain KL, Paylor R (2002). Mouse genetic models for prepulse inhibition: an early review. Molecular Psychiatry 7, 1039-1053.
20. Gonzalez-Burgos G, Lewis DA (2008). GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophrenia Bulletin 34, 944-961.
21. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, et al. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Archives of General Psychiatry 57, 1061-1069.
22. Hashimoto T, Bergen SE, Nguyen QL, Xu B, et al. (2005). Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. Journal of Neuroscience 25, 372-383.
23. Herrmann CS, Fründ I, Lenz D (2010). Human gamma-band activity: a review on cognitive and behavioral correlates and network models. Neuroscience and Biobehavioral Reviews 34, 981-992.
24. Huang ZJ, Kirkwood A, Pizzorusso T, Porciatti V, et al. (1999). BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98, 739-755.
25. Hughes RN (2004). The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neuroscience and Biobehavioral Reviews 28, 497-505.
26. Krueger DD, Howell JL, Hebert BF, Olausson P, et al. (2006). Assessment of cognitive function in the heterozygous reeler mouse. Psychopharmacology 189, 95-104.
27. Lesort M, Lee M, Tucholski J, Johnson GV (2003). Cystamine inhibits caspase activity. mplications for the treatment of polyglutamine disorders. Journal of Biological Chemistry 278, 3825-3830.
28. Lewis DA, Cho RY, Carter CS, Eklund K, et al. (2008). Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. American Journal of Psychiatry 165, 1585-1593.
29. Lewis DA, Moghaddam B (2006). Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Archives of Neurology 63, 1372-1376.
30. Liu WS, Pesold C, Rodriguez MA, Carboni G, et al. (2001). Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proceedings of the National Academy of Sciences USA 98, 3477-3482.
31. LoTurco JJ, Owens DF, Heath MJ, Davis MB, et al. (1995). GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 15, 1287-1298.
32. Martin S, Jones M, Simpson E, van den BM (2003). Impaired spatial reference memory in aromatase-deficient (ArKO) mice. Neuroreport 14, 1979-1982.
33. Mizuno K, Carnahan J, Nawa H (1994). Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Developmental Biology 165, 243-256.
34. Nullmeier S, Panther P, Dobrowolny H, Frotscher M, et al. (2011). Region-specific alteration of GABAergic markers in the brain of heterozygous reeler mice. European Journal of Neuroscience 33, 689-698.
35. Oliverio S, Amendola A, Rodolfo C, Spinedi A, et al. (1999). Inhibition of 'tissue' transglutaminase increases cell survival by preventing apoptosis. Journal of Biological Chemistry 274, 34123-34128.
36. Owens DF, Kriegstein AR (2002). Developmental neurotransmitters? Neuron 36, 989-991.
37. Pappas GD, Kriho V, Pesold C (2001). Reelin in the extracellular matrix and dendritic spines of the cortex and hippocampus: a comparison between wild type and heterozygous reeler mice by immunoelectron microscopy. Journal of Neurocytology 30, 413-425.
38. Paxinos G, Franklin KBJ (2001). The Mouse Brain in Stereotaxic Coordinates, 2nd edn. San Diego: Academic Press.
39. Paylor R, Crawley JN (1997). Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology 132, 169-180.
40. Pillai A, Mahadik SP (2008). Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia. Schizophrenia Research 100, 325-333.
41. Pillai A, Veeranan-Karmegam R, Dhandapani KM, Mahadik SP (2008). Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex. Journal of Neurochemistry 107, 941-951.
42. Podhorna J, Didriksen M (2004). The heterozygous reeler mouse: behavioural phenotype. Behavioral Brain Research 153, 43-54.
43. Qiu S, Korwek KM, Pratt-Davis AR, Peters M, et al. (2006). Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Neurobiology of Learning and Memory 85, 228-242.
44. Rohrer B, Blanco R, Marc RE, Lloyd MB, et al. (2004). Functionally intact glutamate-mediated signaling in bipolar cells of the TRKB knockout mouse retina. Visual Neuroscience 21, 703-713.
45. Salinger WL, Ladrow P, Wheeler C (2003). Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation. Behavioral Neuroscience 117, 1257-1275.
46. Schreiber R, Dalmus M, De Vry J (2002). Effects of alpha 4/beta 2-and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice. Psychopharmacology 159, 248-257.
47. Seidah NG, Mowla SJ, Hamelin J, Mamarbachi AM, et al. (1999). Mammalian subtilisin/kexin isozyme SKI-1: a widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. Proceedings of the National Academy of Sciences USA 96, 1321-1326.
48. Spoerri PE (1988). Neurotrophic effects of GABA in cultures of embryonic chick brain and retina. Synapse 2, 11-22.
49. Takahashi M, Shirakawa O, Toyooka K, Kitamura N, et al. (2000). Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of chizophrenic patients. Molecular Psychiatry 5, 293-300.
50. Terry AV, Gearhart DA, Mahadik SP, Warsi S, et al. (2005). Chronic exposure to typical or atypical antipsychotics in rodents: temporal effects on central alpha 7 nicotinic acetylcholine receptors. Neuroscience 136, 519-529.
51. Thompson Ray M, Weickert CS, Wyatt E, Webster MJ (2011). Decreased BDNF, trkB-TK+ and GAD(67) mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. Journal of Psychiatry and Neuroscience 36, 100048.
52. Tueting P, Costa E, Dwivedi Y, Guidotti A, et al. (1999). The phenotypic characteristics of heterozygous reeler mouse. Neuroreport 10, 1329-1334.
53. Wahlsten D, Metten P, Phillips TJ, Boehm II SL, et al. (2003). Different data from different labs: lessons from studies of gene-environment interaction. Journal of Neurobiology 54, 283-311.
54. Weickert CS, Ligons DL, Romanczyk T, Ungaro G, et al. (2005). Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Molecular Psychiatry 10, 637-650.
55. Woo NH, Lu B (2006). Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist 12, 43-56.
56. Yamada MK, Nakanishi K, Ohba S, Nakamura T, et al. (2002). Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. Journal of Neuroscience 22, 7580-7585.